✦ LIBER ✦

The α1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

✍ Scribed by Michaela Kozàkovà; Jean Marco; Gerd Heusch; Monique Bernies; Irene M Bossi; Carlo Palombo; Gian Battista Anguissola; Francesco Donatelli; Jean Pierre Laurent; Luisa Gregorini

Book ID: 116189384
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 136 KB
Volume: 147
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2003.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

✍ Hirano, Masaharu; Yamashina, Akira; Hara, Kazuhiro; Ikari, Yuji; Jinzaki, Masahi 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 413 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Bari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB